✦ LIBER ✦

Advanced lung adenocarcinoma in an EGFR-positive patient treated with Erlotinib for 52 months

✍ Scribed by Gonçalves, Ivone; Ladeira, Inês; Castro, Ana; Antunes, Ana; Barroso, Ana; Parente, Bárbara

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib Versus Radiation Therapy for B

✍ Gerber, Naamit K.; Yamada, Yoshiya; Rimner, Andreas; Shi, Weiji; Riely, Gregory 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Role of EGFR SNPs in survival of advance

✍ Zhang, Li; Yuan, Xianglin; Chen, Yuan; Du, Xiao-Juan; Yu, Shiying; Yang, Ming 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 451 KB

A randomized phase 2 trial of erlotinib

✍ Li, Ning; Ou, Wei; Yang, Hua; Liu, Qian-Wen; Zhang, Song-Liang; Wang, Bao-Xiao; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

9022 The nicotinic acetylcholine recepto

✍ Cardona, A.; Ramirez, J.L.; De Aguirre, I.; Benlloch, S.; Porta, R.; Palmero, R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase I dose-escalation study of oral vi

✍ Krzakowski, M.; Bennouna, J.; Dansin, E.; Kowalski, D.; Hiret, S.; Penel, N.; Fa 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 316 KB

Gene-guided Gefitinib switch maintenance

✍ Jun Zhu, Te Li, Xiaohui Wang, Ming Ye, Jian Cai, Yuejuan Xu, Bin Wu 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 278 KB